PPA2
protein-codinginorganic pyrophosphatase 2
Gene summary
The protein encoded by this gene is localized to the mitochondrion, is highly similar to members of the inorganic pyrophosphatase (PPase) family, and contains the signature sequence essential for the catalytic activity of PPase. PPases catalyze the hydrolysis of pyrophosphate to inorganic phosphate, which is important for the phosphate metabolism of cells. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~105.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0014973
Submitter: Laboratory for Molecular Medicine
This gene-disease relationship has undergone rapid assessment. Classifications are based on preliminary review of gene-disease validity during analysis of genomic sequencing results.
Inheritance Pattern: AR
Disease ID:MONDO:0014973
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0014973
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0014973
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0005021
Submitter: ClinGen
PPA2 was evaluated for autosomal recessive (AR) dilated cardiomyopathy. PPA2 is a nuclear gene related to mitochondrial function. PPA2 plays roles in mtDNA maintenance, oxidative phosphorylation, generation of ATP, ROS homeostasis, and mitochondrial membrane potential (Phoon et. al, 2020, PMID: 31705601). At the time of this review, dilated cardiomyopathy is the only condition that has been associated with this gene. Human genetic evidence for this gene-disease relationship contains case-level data. At least 9 variants (including missense, nonsense, and frameshift variants) have been reported in humans with DCM in 4 separate publications (Vasilescu et. al, 2018, PMID: 30384889; Zhao et. al, 2021, PMID: 33826954; Guimier et. al, 2021, PMID: 34400813; Manzanilla-Romero et. al, 2023; PMID: 37269378). All cases reported in the literature were infant onset, often in the presence of viral illness, or in teenage/young adulthood in the presence of alcohol consumption. Several cases presented with sudden cardiac death, with limited phenotype information available on autopsy or due to the patient’s young age and were not scored for DCM (Kennedy et. al, 2016, PMID: 27523597; Guimier et. al, 2016, PMID: 27523598; Sanford et. al, 2020, PMID: 33028643; Guimer et. al, 2021, PMID: 34400813; Genthe et. al, 2023, PMID: 37869221; Graham et. al, 2023, PMID: 37249496; González et. al, 2024, PMID: 38582264). In addition, this gene-disease assertion is supported by expression studies and functional alteration. Expression of PPA2 in human heart tissue was demonstrated by northern blot (Curbo et. al, 2006, PMID: 16300924). Decreased expression of PPA2 was demonstrated in western blot of patient homogenates (Kennedy et. al, 2016, PMID: 27523597). In addition, functional alterations were shown in both patient and non-patient cells. Increased oxygen consumption rates were found in PPA2-deficient fibroblasts (Kennedy et. al, 2016, PMID: 27523597). Additionally, yeast PPA2 knockouts showed increased diamide sensitivity, suggesting reduced levels of antioxidants (Kennedy et. al, 2016, PMID: 27523597). In summary, there is strong evidence to support the relationship between PPA2 and AR DCM. This classification was approved by the ClinGen Dilated Cardiomyopathy Working Group on 05/16/2025 (SOP Version 10).
Inheritance Pattern: AR
Disease ID:MONDO:0014973
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0014974
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular
Intervention: General
Rationale: Individuals have been reported as suffering sudden cardiac failure after ingesting small amounts of alcohol, and awareness may allow avoidance of triggering agents as well as early diagnosis allowing preventive measures (eg, ICD)
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PPA2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_176869.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 72 | 1 | 76 | ||
| missense | 3 | 16 | 116 | 14 | 149 | |
| nonsense | 2 | 3 | 4 | 9 | ||
| start loss | 1 | 1 | ||||
| frameshift | 6 | 6 | ||||
| splice donor/acceptor (+/-2bp) | 3 | 6 | 9 | |||
| Total | 5 | 22 | 136 | 86 | 1 | 250 |
Highest pathogenic variant AF is 0.0010266774
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_789845.1 | 12 | MANE Select | |
| Ensembl | ENSP00000343885.5 | 12 | MANE Select | |
| RefSeq | NP_008834.3 | 11 | Standard | |
| RefSeq | NP_789842.2 | 8 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Oxidative phosphorylation - Homo sapiens (human)
- tRNA Aminoacylation
- Translation
- Metabolism of proteins
- Pyrophosphate hydrolysis
Biological Process
- tRNA aminoacylation for protein translation
- protein dephosphorylation
- phosphate-containing compound metabolic process
- regulation of mitochondrial membrane potential
- diphosphate metabolic process
Molecular Function
- magnesium ion binding
- inorganic diphosphatase activity
- protein serine/threonine phosphatase activity
Cellular Component
- mitochondrial matrix
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000341695
- Coding exons
- 12
- Length
- 105005
- Individuals with no LoFs
- 125717
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 31
- Defined
- 125748
- p
- 0.000123
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.435 | 159 | 175 | 0.908 | 0.00000865 | 2184 |
| Missense (PolyPhen) | 61 | 75.552 | 0.80739 | 945 | ||
| Synonymous | 0.318 | 57 | 60.1 | 0.948 | 0.00000293 | 588 |
| Loss of Function | 0.621 | 17 | 20.0 | 0.850 | 9.36e-7 | 255 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00020 | 0.00018 | rare |
| Latino/Admixed American | 0.000062 | 0.000058 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00017 | 0.00016 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00017 | 0.00015 | rare |
| South Asian | 0.00018 | 0.00016 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Hydrolyzes inorganic pyrophosphate (PubMed:27523597). This activity is essential for correct regulation of mitochondrial membrane potential, and mitochondrial organization and function (PubMed:27523598). {ECO:0000269|PubMed:27523597, ECO:0000269|PubMed:27523598}.;
- Disease
- DISEASE: Sudden cardiac failure, infantile (SCFI) [MIM:617222]: A disease characterized by sudden death within the first 2 years of life due to unexpected cardiac arrest. Some patients manifest hypertrophic cardiomyopathy, lipid accumulation in myocardium, degeneration of mitochondrial cristae, metabolic acidosis, and elevated plasma lactate levels. SCFI transmission pattern is consistent with autosomal recessive inheritance. {ECO:0000269|PubMed:27523597, ECO:0000269|PubMed:27523598}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.145
Intolerance Scores
- LoFtool
- 0.940
- RVIS EVS
- 0
- RVIS percentile EVS
- 53.73
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- N
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.597
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | Medium | Medium | Medium |